Jentadueto XR is a prescription tablet that combines two blood sugar-lowering medications, linagliptin and metformin, into a single once-daily pill for adults with type 2 diabetes. It’s designed to be used alongside diet and exercise to improve blood sugar control, and the “XR” stands for extended release, meaning the metformin component is released gradually throughout the day.
What’s Inside the Pill
Jentadueto XR contains two active ingredients that work through different pathways. Linagliptin belongs to a class called DPP-4 inhibitors (sometimes called “gliptins”). Metformin is the most widely prescribed diabetes drug in the world and belongs to the biguanide class. Combining them into one tablet simplifies what would otherwise be two separate pills taken at different times.
The medication comes in two strengths: 2.5 mg linagliptin with 1,000 mg extended-release metformin, or 5 mg linagliptin with 1,000 mg extended-release metformin. Your prescribed strength depends on what doses of each ingredient you need for adequate blood sugar control.
How the Two Ingredients Lower Blood Sugar
Linagliptin works by blocking an enzyme that normally breaks down incretin hormones in your body. Incretins are natural chemicals your gut releases after you eat. They signal your pancreas to produce more insulin when blood sugar rises and tell your liver to ease up on releasing stored glucose. By preventing the breakdown of these hormones, linagliptin keeps their levels higher for longer, which means more insulin when you need it and less sugar dumped by your liver between meals. Importantly, this insulin boost is glucose-dependent: it ramps up when blood sugar is high and backs off when it’s normal, which lowers the risk of blood sugar dropping too far.
Metformin tackles blood sugar from a completely different angle. It reduces the amount of glucose your liver produces, slows how much sugar your intestines absorb from food, and helps your muscles and other tissues take in and use glucose more effectively. Together, the two ingredients cover multiple causes of elevated blood sugar at the same time, which is why a combination pill can work better than either drug alone for people who need more than one medication.
How to Take It
Jentadueto XR is taken once a day with a meal. The tablet must be swallowed whole. Do not split, crush, dissolve, or chew it. The extended-release design relies on the tablet’s intact structure to release metformin slowly. Breaking that structure would release the full dose at once, increasing the chance of side effects (particularly stomach issues) and undermining the steady blood-sugar control the XR formulation provides.
One thing that catches some people off guard: you may occasionally notice what looks like an intact tablet in your stool. This is the empty shell of the tablet after the medication has been absorbed. It does not mean the dose didn’t work.
Common Side Effects
Most side effects from Jentadueto XR come from the metformin component and center on the digestive system. Nausea, diarrhea, stomach pain, and a metallic taste are the most frequently reported issues. These tend to be worst during the first few weeks and often improve as your body adjusts. Taking the tablet with food (as directed) and starting at a lower dose before increasing helps reduce stomach upset.
Upper respiratory symptoms like a stuffy or runny nose (nasopharyngitis) have also been reported with the linagliptin component, though they’re generally mild.
Lactic Acidosis: A Rare but Serious Risk
Jentadueto XR carries a boxed warning (the FDA’s most prominent safety alert) about lactic acidosis, a condition where lactic acid builds up in the blood faster than the body can clear it. This risk comes from the metformin component. It is rare, occurring in roughly 0.03 cases per 1,000 patient-years, but it can be life-threatening when it does happen.
Several factors raise the risk: significant kidney problems, liver disease, heavy alcohol use, dehydration, and conditions that reduce oxygen delivery to tissues like severe heart failure. Kidney function matters most because metformin is cleared almost entirely through the kidneys. When the kidneys can’t remove it efficiently, metformin accumulates and lactic acid levels can climb. Your doctor will check your kidney function before prescribing this medication and periodically while you’re on it.
Early signs of lactic acidosis are vague and easy to dismiss: unusual tiredness, muscle aches, trouble breathing, unexpected stomach discomfort, or feeling unusually cold. Because the symptoms aren’t specific, the key is being aware that these feelings, especially in combination, warrant prompt medical attention if they develop.
Heart Failure Concerns With DPP-4 Inhibitors
Some DPP-4 inhibitors have been linked to an increased risk of hospitalization for heart failure. This raised questions about the entire drug class. However, linagliptin (the DPP-4 inhibitor in Jentadueto XR) was specifically studied in the large CARMELINA trial and showed no increased risk of heart failure or related outcomes compared to placebo. Not all drugs in this class carry the same risk, and the evidence for linagliptin has been reassuring on this front.
Who Jentadueto XR Is Typically For
This medication is generally prescribed for adults with type 2 diabetes who need both linagliptin and metformin to manage their blood sugar. That typically means people who aren’t reaching their blood sugar goals on metformin alone and are adding a DPP-4 inhibitor, or people already taking both medications separately who want the convenience of a single daily tablet. It is not used for type 1 diabetes or for treating diabetic ketoacidosis.
Because the metformin component requires adequate kidney function to be used safely, people with severe kidney impairment are not candidates for this medication. Alcohol should be limited while taking it, as heavy drinking increases both the risk of lactic acidosis and the chance of low blood sugar.